University of Michigan researchers find that racially biased pulse oximeter readings may further limit opportunities for Black patients with heart failure — who are already less likely to get treatment — to receive potentially lifesaving therapies, such as heart pumps and transplants.
A heart pump can save left heart failure patients’ lives, but the surgery to implant the pump often leads to right heart failure. Doctors now have a way to predict which patients are most at risk.
The Heart Failure Society of America (HFSA) is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation and advocacy. Its annual scientific meeting held Oct. 6-9, in Cleveland offers the best heart failure…
Scott Stewart, DNP, APNC, CNL, Mechanical Circulatory Support Program supervisor at Hackensack Meridian Hackensack University Medical Center, co-authored a first-of-its-kind textbook titled, “A Guide to Mechanical Circulatory Support: A Primer for Ventricular Assist Device (VAD) Clinicians.”
While it may look like any other holiday party with food, music and decorations, it’s the party-goers that make this celebration quite unique – many of them have advanced heart failure and are in need of a heart transplant. Still,…
Black people and women with severe heart failure who might be good candidates for surgery to implant a heart-assisting device have a lower chance of actually getting that operation than white patients, or male patients, a new study finds.
Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant a newly-designed mechanical pump in a patient with severe heart failure.
In a new multicenter study, researchers led by University of Utah Health physicians report that an emerging heart failure treatment could potentially reverse structural damage to the heart, allowing it to heal itself over time. Overall, 19 (40%) patients who were treated with a combination of LVAD support with heart failure medications had sufficient improvement that the LVAD could be removed.
Travel restrictions imposed to curb the spread of COVID-19 are making it more difficult for some heart failure patients who have artificial heart pumps to participate in follow-up care at implantation centers far from their homes. But a new study suggests there may be a viable alternative.
According to University of Utah Health researchers, local doctors in rural areas who receive specialized training in managing the devices and who work in conjunction with cardiovascular experts at a major medical center can care for these patients safely and effectively.
The 8th annual Utah Cardiac Recovery Symposium (U-CARS) will host thought leaders and noted speakers from around the globe to discuss ground-breaking research in the field of cardiac recovery.
MedStar Heart & Vascular Institute has enrolled its first patient to a clinical trial to determine whether cardiac stem cells reduce inflammation enough to improve heart function in patients with heart failure severe enough to require a left ventricular assist device, or LVAD.
ANN ARBOR, Mich. — Mitral valve procedures are often not performed because of the standing belief that LVAD support resolves mitral regurgitation, due to better left heart performance. A new study in The Journal of Thoracic and Cardiovascular Surgery found when…